相关实验视频
Updated: Jul 19, 2025

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
Published on: April 7, 2023
托法西提尼布治疗耐火性炎症性肌肉炎:一项对41名患者的回顾性队列研究
Madelaine Beckett1, Julia Tan2, Evelyne Bonnardeaux3
1Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
托法西替尼在炎症性肌肉炎患者中有效治疗皮肤症状,但显示肌肉力量的改善有限. 许多患者因缺乏益处或死亡而停止服用该药物.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
背景情况:
- 炎症性肌肉炎是一组罕见的自身免疫性疾病,导致肌肉炎症.
- 治疗不耐药的病例带来了重大挑战,需要新的治疗方法.
- 托法西提尼布是一种Janus激酶抑制剂,在各种自身免疫性疾病中表现有前途.
研究的目的:
- 评估托法西提尼布在治疗不耐药的炎症性肌肉炎患者的实际疗效和安全性.
- 评估托法西提尼布对皮肤和肌肉表现的影响.
主要方法:
- 回顾41名炎症性肌肉炎患者的医疗记录,这些患者接受了托法西提尼布治疗.
- 患者包括那些患有皮肤肌炎 (DM),骨髓病性DM (ADM) 和多肌炎 (PM) 现型的患者.
- 收集关于疾病反应,不良事件和停止治疗的原因的数据.
主要成果:
- 托法西替尼在经典的DM和ADM患者的皮肤疾病活性显著改善.
- 在所有肌肉炎表型中没有观察到肌肉力量的有意义的改善.
- 超过一半的患者 (53.7%) 由于缺乏疗效或死亡而停止服用tofacitinib.
结论:
- 托法西替尼在DM和ADM的皮肤表现方面是有效的.
- 它在炎症性肌肉炎中提高肌肉力量的效用是有限的.
- 需要进一步的研究来优化tofacitinib在这个患者群体中的使用.
更多相关视频
06:35An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
08:09Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice
Published on: March 24, 2017
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Myocarditis III: Medical Management